Concepts (82)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Furocoumarins | 4 | 2021 | 67 | 2.59 | Why? |
| Virus Inactivation | 4 | 2021 | 1139 | 0.98 | Why? |
| Ultraviolet Rays | 3 | 2021 | 1272 | 0.87 | Why? |
| Promoter Regions, Genetic | 3 | 2018 | 823 | 0.78 | Why? |
| Blood Component Removal | 1 | 2021 | 175 | 0.76 | Why? |
| Interleukin-1beta | 2 | 2018 | 992 | 0.59 | Why? |
| Photosensitizing Agents | 1 | 2017 | 279 | 0.58 | Why? |
| Blood Safety | 1 | 2019 | 459 | 0.54 | Why? |
| Plasma Exchange | 1 | 2021 | 763 | 0.53 | Why? |
| Blood Platelets | 2 | 2021 | 1704 | 0.46 | Why? |
| Blood Transfusion | 1 | 2021 | 1399 | 0.45 | Why? |
| Plasma | 2 | 2020 | 1809 | 0.44 | Why? |
| Blood Donors | 3 | 2021 | 2956 | 0.44 | Why? |
| Middle East Respiratory Syndrome Coronavirus | 3 | 2020 | 8843 | 0.37 | Why? |
| Polymorphism, Single Nucleotide | 3 | 2018 | 3607 | 0.20 | Why? |
| Ultraviolet Therapy | 1 | 2020 | 138 | 0.19 | Why? |
| Health Knowledge, Attitudes, Practice | 1 | 2021 | 8811 | 0.18 | Why? |
| Arabs | 2 | 2018 | 298 | 0.17 | Why? |
| Plasmapheresis | 1 | 2021 | 437 | 0.17 | Why? |
| Diabetes Mellitus, Type 2 | 1 | 2018 | 6166 | 0.16 | Why? |
| Viral Plaque Assay | 1 | 2017 | 381 | 0.15 | Why? |
| Gene Frequency | 2 | 2018 | 1210 | 0.15 | Why? |
| Cytopathogenic Effect, Viral | 1 | 2017 | 635 | 0.15 | Why? |
| Saudi Arabia | 4 | 2020 | 4423 | 0.14 | Why? |
| Immunization, Passive | 5 | 2021 | 10067 | 0.14 | Why? |
| Coronary Artery Disease | 2 | 2017 | 2570 | 0.12 | Why? |
| Vero Cells | 2 | 2019 | 14117 | 0.11 | Why? |
| ABO Blood-Group System | 1 | 2021 | 995 | 0.11 | Why? |
| Interleukin-10 | 1 | 2017 | 1409 | 0.10 | Why? |
| Killer Cells, Natural | 1 | 2017 | 2093 | 0.08 | Why? |
| Case-Control Studies | 3 | 2018 | 17671 | 0.07 | Why? |
| Cardiovascular Diseases | 2 | 2021 | 11497 | 0.07 | Why? |
| Humans | 17 | 2021 | 930598 | 0.06 | Why? |
| B-Lymphocytes | 1 | 2017 | 4418 | 0.06 | Why? |
| RNA, Viral | 2 | 2021 | 32276 | 0.06 | Why? |
| Myocardial Infarction | 1 | 2017 | 3361 | 0.05 | Why? |
| Animals | 3 | 2020 | 78931 | 0.05 | Why? |
| Blood Grouping and Crossmatching | 1 | 2021 | 125 | 0.05 | Why? |
| Treatment Outcome | 3 | 2021 | 51732 | 0.05 | Why? |
| T-Lymphocytes | 1 | 2017 | 6670 | 0.05 | Why? |
| Transfusion Reaction | 1 | 2020 | 245 | 0.04 | Why? |
| Real-Time Polymerase Chain Reaction | 1 | 2017 | 11367 | 0.04 | Why? |
| CD56 Antigen | 1 | 2017 | 193 | 0.04 | Why? |
| Viral Load | 1 | 2017 | 15850 | 0.04 | Why? |
| Pandemics | 2 | 2021 | 389249 | 0.04 | Why? |
| Virus Replication | 1 | 2017 | 14331 | 0.04 | Why? |
| CD3 Complex | 1 | 2017 | 237 | 0.04 | Why? |
| GPI-Linked Proteins | 1 | 2017 | 317 | 0.04 | Why? |
| Middle Aged | 5 | 2021 | 270681 | 0.04 | Why? |
| Male | 6 | 2021 | 367725 | 0.03 | Why? |
| Female | 6 | 2021 | 380317 | 0.03 | Why? |
| Cross-Sectional Studies | 1 | 2021 | 53120 | 0.03 | Why? |
| Adolescent | 2 | 2021 | 86841 | 0.03 | Why? |
| Receptors, IgG | 1 | 2017 | 578 | 0.03 | Why? |
| Camelus | 1 | 2020 | 1425 | 0.03 | Why? |
| Health Care Surveys | 1 | 2020 | 2942 | 0.03 | Why? |
| Heart Transplantation | 1 | 2021 | 1293 | 0.03 | Why? |
| Retrospective Studies | 1 | 2021 | 105322 | 0.02 | Why? |
| Adult | 3 | 2021 | 244371 | 0.02 | Why? |
| Research | 1 | 2020 | 2115 | 0.02 | Why? |
| Guidelines as Topic | 1 | 2020 | 2844 | 0.02 | Why? |
| Antibodies, Viral | 1 | 2020 | 51949 | 0.02 | Why? |
| Tumor Necrosis Factor-alpha | 1 | 2017 | 2483 | 0.02 | Why? |
| Gene Expression | 1 | 2017 | 3332 | 0.02 | Why? |
| Lymphocyte Count | 1 | 2017 | 4758 | 0.02 | Why? |
| Developing Countries | 1 | 2020 | 4283 | 0.02 | Why? |
| Enzyme-Linked Immunosorbent Assay | 1 | 2020 | 7868 | 0.02 | Why? |
| Seroepidemiologic Studies | 1 | 2020 | 10017 | 0.02 | Why? |
| Research Design | 1 | 2020 | 5830 | 0.02 | Why? |
| Genetic Predisposition to Disease | 1 | 2017 | 4027 | 0.01 | Why? |
| Coronavirus Infections | 2 | 2021 | 253789 | 0.01 | Why? |
| Clinical Trials as Topic | 1 | 2020 | 7330 | 0.01 | Why? |
| Host-Pathogen Interactions | 1 | 2021 | 11041 | 0.01 | Why? |
| Infant, Newborn | 1 | 2020 | 23105 | 0.01 | Why? |
| Prognosis | 1 | 2021 | 32490 | 0.01 | Why? |
| Risk Assessment | 1 | 2021 | 25439 | 0.01 | Why? |
| Comorbidity | 1 | 2021 | 34796 | 0.01 | Why? |
| Prospective Studies | 1 | 2021 | 43301 | 0.01 | Why? |
| Risk Factors | 1 | 2021 | 71621 | 0.01 | Why? |
| Child | 1 | 2020 | 70012 | 0.01 | Why? |
| Young Adult | 1 | 2020 | 93724 | 0.01 | Why? |
| Aged | 1 | 2017 | 215776 | 0.00 | Why? |
Hindawi's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts
(82)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(144)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_